IndiviorINDV
Market Cap: $1.26B
About: Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
Employees: 1,164
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
33% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 15
5% more funds holding
Funds holding: 94 [Q1] → 99 (+5) [Q2]
9% more call options, than puts
Call options by funds: $8.18M | Put options by funds: $7.51M
0.33% more ownership
Funds ownership: 48.02% [Q1] → 48.34% (+0.33%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 4 [Q1] → 4 (+0) [Q2]
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
64% less capital invested
Capital invested by funds: $3.36B [Q1] → $1.22B (-$2.14B) [Q2]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Piper Sandler David Amsellem 66% 1-year accuracy 23 / 35 met price target | 127%upside $22 | Overweight Reiterated | 13 Sept 2024 |
Piper Sandler David Amsellem 66% 1-year accuracy 23 / 35 met price target | 127%upside $22 | Overweight Initiated | 23 Jul 2024 |
Craig-Hallum Chase Knickerbocker 39% 1-year accuracy 7 / 18 met price target | 148%upside $24 | Buy Maintained | 10 Jul 2024 |
Financial journalist opinion
Based on 265 articles about INDV published over the past 30 days